Berger Disease
·MeSH: Glomerulonephritis, IGA
Prevalence
30.0 / 100K
2 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(2)
| Drug | Company |
|---|---|
| drug | NOVARTIS AG (NVSEF) |
| drug | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Berger Disease?
BioSniper tracks 2 drugs in development for Berger Disease across 2 companies.
How many clinical trials target Berger Disease?
There are 4 clinical trials targeting Berger Disease tracked by BioSniper.
What is the prevalence of Berger Disease?
The estimated prevalence of Berger Disease is approximately 30.0 per 100,000 population.
Deep-dive into Berger Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis